menu
    • menu

    Company profile for Mitsubishi Tanabe Pharma America

    NEW Drugs in Dev: 9
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a biopharmaceutical company focused on developing innovative treatments for serious and complex diseases. As a U.S. subsidiary of Mitsubishi Tanabe Pharma Corporation, we draw upon over 300 years of pharmaceutical heritage while advancing modern therapies in neurology, immunology and rare diseases. Our team is committed to translating scientific discovery into meaningful therapi...
    Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a biopharmaceutical company focused on developing innovative treatments for serious and complex diseases. As a U.S. subsidiary of Mitsubishi Tanabe Pharma Corporation, we draw upon over 300 years of pharmaceutical heritage while advancing modern therapies in neurology, immunology and rare diseases. Our team is committed to translating scientific discovery into meaningful therapies that address unmet medical needs. We maintain rigorous research standards and collaborate with healthcare partners to deliver transformative solutions for patients who need them most.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mitsubishi Tanabe Pharma AmericaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Jersey City, New Jersey
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mt-pharma-america.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mitsubishi-tanabe-pharma-america/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tanabe Pharma America Completes RADICAVA Transfer To Shionogi
    Tanabe Pharma America Completes RADICAVA Transfer To Shionogi

    02 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tanabe-pharma-america-announces-finalization-of-radicava-edaravone-transfer-to-shionogi-302731930.html

    PR NEWSWIRE
    02 Apr 2026
    Share Share
    Tanabe Pharma America Showcases ALS Research At MDA 2026
    Tanabe Pharma America Showcases ALS Research At MDA 2026

    05 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tanabe-pharma-america-to-highlight-research-in-als-at-2026-mda-clinical-and-scientific-conference-302704536.html

    PR NEWSWIRE
    05 Mar 2026
    Share Share
    Experimental Drug Scores In Ph. 3 For Painful Sunlight Disorders
    Experimental Drug Scores In Ph. 3 For Painful Sunlight Disorders

    22 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tanabe-pharmas-oral-drug-scores-ph-3-rare-disease-study-though-details-remain-dark

    FIERCE BIOTECH
    22 Jan 2026
    Share Share
    Tanabe Pharma America Showcases Edaravone's ALS Mechanisms
    Tanabe Pharma America Showcases Edaravone's ALS Mechanisms

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tanabe-pharma-america-to-present-preclinical-research-at-mnda-on-edaravones-potential-mechanisms-in-als-302631895.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share
    Mitsubishi Tanabe Pharma America Is Now Tanabe Pharma America
    Mitsubishi Tanabe Pharma America Is Now Tanabe Pharma America

    01 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-is-now-tanabe-pharma-america-302629118.html

    PR NEWSWIRE
    01 Dec 2025
    Share Share
    Mitsubishi Tanabe Pharma To Unveil Investigational ND0612 Data
    Mitsubishi Tanabe Pharma To Unveil Investigational ND0612 Data

    03 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-to-present-new-data-on-investigational-nd0612-at-the-2025-international-congress-of-parkinsons-disease-and-movement-disorders-302574239.html

    PR NEWSWIRE
    03 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search